Many studies link tobacco smoking to lung cancer. New research adds that where people live can also change a person’s risk. The work is published in BMC Public Health.
The paper lists Veronica Bernacchi as a coauthor. She is an assistant professor at the Michigan State University College of Nursing. Other contributors come from a public health department, a hospital system and a college of medicine.
The researchers used public county data from the 2022 County Health Rankings and Roadmaps website. The short summary highlights that geography matters along with known individual risks such as smoking. The summary does not give detailed methods or policy steps, so readers must consult the full paper for more information.
Difficult words
- tobacco — the plant smoked in cigarettes and products
- lung cancer — a disease when cancer grows in the lungs
- risk — chance that something bad may happen to healthrisks
- coauthor — a person who writes a paper with others
- assistant professor — a university teacher with an early academic job
- geography — the study of places and where people live
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Do you think where you live can affect your health? Why or why not?
- Why should readers consult the full paper rather than only the short summary?
Related articles
New oral Listeria vaccine shows promise against colorectal cancer
Researchers report a modified oral vaccine made from Listeria that primes immune cells in the gut and limits tumor growth in mice. The vaccine worked best when combined with immune checkpoint inhibitors and caused few side effects.
AI and citizen photos identify Anopheles stephensi in Madagascar
Scientists used AI and a citizen photo from the GLOBE Observer app to identify Anopheles stephensi in Madagascar. The study shows how apps, a 60x lens and a dashboard can help monitor this urban malaria mosquito, but access and awareness limit use.
Experimental vaccine gives lasting protection in mice against CCHF
A new mouse study reports an experimental vaccine that produced rapid protection and antibodies that lasted up to 18 months. Researchers say a booster strengthened and extended immune responses and plan manufacturing steps before human trials.
